AAAAAA
Results:
1-18
|
Results: 18
Authors:
CHARLON V
KOBRIN I
Citation: V. Charlon et I. Kobrin, THE EFFICACY AND SAFETY OF MIBEFRADIL IN SUBGROUPS OF PATIENTS WITH CHRONIC STABLE ANGINA-PECTORIS, International journal of clinical practice, 52(4), 1998, pp. 257-264
Authors:
KRUM H
LACOURCIERE Y
CHARLON V
Citation: H. Krum et al., BOSENTAN IN ESSENTIAL-HYPERTENSION - REPLY, The New England journal of medicine, 339(5), 1998, pp. 347-347
Authors:
KRUM H
VISKOPER RJ
LACOURCIERE Y
BUDDE M
CHARLON V
Citation: H. Krum et al., THE EFFECT OF AN ENDOTHELIN-RECEPTOR ANTAGONIST, BOSENTAN, ON BLOOD-PRESSURE IN PATIENTS WITH ESSENTIAL-HYPERTENSION, The New England journal of medicine, 338(12), 1998, pp. 784-790
Authors:
PACKER M
CASPI A
CHARLON V
LAROCHE H
COHENSOLAL A
KIOWSKI W
KOSTUK W
KRUM H
LEVINE B
MASSIE B
MCMURRAY J
RIZZON P
SWEDBERG K
Citation: M. Packer et al., MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF LONG-TERM ENDOTHELIN BLOCKADE WITH BOSENTAN IN CHRONIC HEART-FAILURE - RESULTS OF THE REACH-1 TRIAL, Circulation, 98(17), 1998, pp. 12-12
Authors:
KOBRIN I
BIESKA G
CHARLON V
LINDBERG E
PORDY R
Citation: I. Kobrin et al., ANTIANGINAL AND ANTIISCHEMIC EFFECTS OF MIBEFRADIL, A NEW T-TYPE CALCIUM-CHANNEL ANTAGONIST, Cardiology, 89, 1998, pp. 23-32
Authors:
SCHNEEWEISS A
KOBRIN I
CHARLON V
CASPI A
MARMOR A
SCLAROVSKY S
REISIN L
SCHLESINGER Z
Citation: A. Schneeweiss et al., ADDING THE NEW CALCIUM-ANTAGONIST MIBEFRADIL TO PATIENTS RECEIVING LONG-TERM BETA-BLOCKER THERAPY RESULTS IN IMPROVED ANTIANGINAL AND ANTIISCHEMIC EFFICACY, The American heart journal, 135(2), 1998, pp. 272-280
Authors:
KOBRIN I
CHARLON V
Citation: I. Kobrin et V. Charlon, PREDICTABLE CLINICAL EFFECTS IN THE TREATMENT OF HYPERTENSION AND CHRONIC, STABLE ANGINA-PECTORIS - CLINICAL-STUDIES OF MIBEFRADIL, Journal of hypertension, 15, 1997, pp. 35-40
Authors:
KOBRIN I
CHARLON V
LINDBERG E
NEUMANN N
PORDY R
Citation: I. Kobrin et al., MIBEFRADIL - A NEW T-CHANNEL SELECTIVE CALCIUM-ANTAGONIST, Medicamentos de actualidad, 33(8), 1997, pp. 523-542
Authors:
KOBRIN I
CHARLON V
BURSZTYN M
Citation: I. Kobrin et al., NEW DEVELOPMENTS IN DRUG-THERAPY OF HYPERTENSION, The Medical clinics of North America, 81(6), 1997, pp. 1359
Authors:
KRUM H
BUDDE M
CHARLON V
Citation: H. Krum et al., EFFECT OF ENDOTHELIN RECEPTOR ANTAGONISM ON REFLEX NEUROHORMONAL VASOCONSTRICTOR ACTIVATION IN PATIENTS WITH ESSENTIAL-HYPERTENSION, Circulation, 96(8), 1997, pp. 2279-2279
Authors:
ALPERT JS
BAKX A
SCHNEEWEISS A
CASPI A
CHARLON V
KOBRIN I
Citation: Js. Alpert et al., TREATMENT OF CHRONIC STABLE ANGINA-PECTORIS WITH COMBINATION MIBEFRADIL AND BETA-BLOCKER THERAPY, Circulation, 96(8), 1997, pp. 2607-2607
Authors:
KRUM H
BUDDE M
CHARLON V
Citation: H. Krum et al., ENDOTHELIN CONTRIBUTES TO BLOOD-PRESSURE ELEVATIONS IN PATIENTS WITH MILD-MODERATE ESSENTIAL-HYPERTENSION - EVIDENCE FROM TREATMENT WITH A MIXED ENDOTHELIN RECEPTOR ANTAGONIST, BOSENTAN, Circulation, 96(8), 1997, pp. 3340-3340
Authors:
KOBRIN I
CHARLON V
LINDBERG E
PORDY R
Citation: I. Kobrin et al., SAFETY OF MIBEFRADIL, A NEW ONCE-A-DAY, SELECTIVE T-TYPE CALCIUM-CHANNEL ANTAGONIST, The American journal of cardiology, 80(4B), 1997, pp. 40-46
Authors:
CHARLON V
DOLLOW S
FIDEL J
HOGLUND C
HONKANEN T
KOBRIN I
MCEWAN J
MCINNES G
VISKOPER JR
WOO KS
Citation: V. Charlon et al., REPRODUCIBILITY OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR INDUCED COUGH - A DOUBLE-BLIND RANDOMIZED STUDY, British journal of clinical pharmacology, 39(2), 1995, pp. 125-129
Authors:
VISKOPER RJ
CHARLON V
LASZT A
YOSEFY C
BOCK J
LANDAU M
KOBRIN I
Citation: Rj. Viskoper et al., TIME DEPENDENCY OF THE ANTIHYPERTENSIVE EFFICACY OF THE NEW RENIN INHIBITOR RO 42-5892, Journal of human hypertension, 8(2), 1994, pp. 133-136
Authors:
COUDRAY C
CHARLON V
DELEIRIS J
FAVIER A
Citation: C. Coudray et al., XANTHINE-OXIDASE AND ANTIOXIDANT ENZYME-ACTIVITIES AND GLUTATHIONE CONTENT IN INFARCT RAT HEARTS, Biochemical archives, 10(2), 1994, pp. 79-86
Authors:
KOBRIN I
VISKOPER RJ
LASZT A
BOCK J
WEBER C
CHARLON V
Citation: I. Kobrin et al., EFFECTS OF AN ORALLY ACTIVE RENIN INHIBITOR, RO 42-5892, IN PATIENTS WITH ESSENTIAL-HYPERTENSION, American journal of hypertension, 6(5), 1993, pp. 349-356
Authors:
COUDRAY C
CHARLON V
DELEIRIS J
FAVIER A
Citation: C. Coudray et al., EFFECT OF ZINC-DEFICIENCY ON LIPID-PEROXIDATION STATUS AND INFARCT SIZE IN RAT HEARTS, International journal of cardiology, 41(2), 1993, pp. 109-113
Risultati:
1-18
|